Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Breathtec Biomedical, Inc. (BTHCF)

Total paid for Promotions this month: $25,000
E-mails this Month: 24
Estimated Volume Generated: $0
Research Report on BTHCF: Click to see
* The information presented is based on information for Apr , 2016
  Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility View this email in your browser Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility -- City of Surrey’s Health &Technology District to host Breathtec’s in-licensed Na-Nose ...read more
Promoter: Five Star Equities Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility View this email in your browser Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility -- City of Surrey’s Health &Technology District to host Breathtec’s in-licensed Na-Nose ...read more
Promoter: The Bedford Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility View this email in your browser Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility -- City of Surrey’s Health &Technology District to host Breathtec’s in-licensed Na-Nose ...read more
Promoter: Paragon Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Lung cancer breath 'signature' presents promise for earlier diagnosis View this email in your browser Lung cancer breath 'signature' presents promise for earlier diagnosis A single breath may be all it takes to identify the return of lung cancer after surgery, according to a study released by The Annals of Thoracic Surgery.   ...read more
Promoter: The Bedford Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  The Wall Street Journal: “Breath Research is hot right now!” View this email in your browser The Wall Street Journal: “Breath Research is hot right now!” Respected Wall Street Journal highlights Mass Spectrometry and Breath Research in new article   Dear Members, The ...read more
Promoter: The Bedford Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company View this email in your browser Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company BTHCF Closes Licensing Deal of Na-NOSE Technology and Announces ...read more
Promoter: Paragon Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company View this email in your browser Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company BTHCF Closes Licensing Deal of Na-NOSE Technology and Announces ...read more
Promoter: The Bedford Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company View this email in your browser Shareholder’s and Potential Investors – Breaking News has been Released by Breathtec Biomedical (BTHCF) our Featured Company BTHCF Closes Licensing Deal of Na-NOSE Technology and Announces ...read more
Promoter: Five Star Equities Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Why Breathtec Biomedical Inc. (BTHCF) is a Strong Investment Opportunity View this email in your browser Why Breathtec Biomedical Inc. (BTHCF) is a Strong Investment Opportunity   Dear Members, Breathtec Biomedical Inc. is aiming to develop and commercialize breath analysis screening technologies. ...read more
Promoter: The Bedford Report Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
  Why Breathtec Biomedical Inc. (BTHCF) is a Strong Investment Opportunity View this email in your browser Why Breathtec Biomedical Inc. (BTHCF) is a Strong Investment Opportunity   Dear Members, Breathtec Biomedical Inc. is aiming to develop and commercialize breath analysis screening technologies. ...read more
Promoter: Five Star Equities Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
BTHCF $25,000 UNKNOWN
Max Profit: 4.08 % Gain at close: Pending
First  >> Last